In summary, along with the observation that FOXC1 and NR2F2 co-interact, it is likely that core binding sites of FOXC1 in TNBC identified here and represented by cluster 1 and cluster 4 peaks, are sites where FOXA1/NR2F2 are bound in luminal breast cancer (and vice versa). The gene discussed is FOXA1; the disease is breast cancer.